Hypertrophic cardiomyopathy detection with artificial intelligence electrocardiography in international cohorts: an external validation study.

Siontis, Konstantinos C; Wieczorek, Mikolaj A; Maanja, Maren; Hodge, David O; Kim, Hyung-Kwan; Lee, Hyun-Jung; Lee, Heesun; Lim, Jaehyun; Park, Chan Soon; Ariga, Rina; Raman, Betty; Mahmod, Masliza; Watkins, Hugh; Neubauer, Stefan; Windecker, Stephan; Siontis, George C M; Gersh, Bernard J; Ackerman, Michael J; Attia, Zachi I; Friedman, Paul A; ... (2024). Hypertrophic cardiomyopathy detection with artificial intelligence electrocardiography in international cohorts: an external validation study. European heart journal. Digital health, 5(4), pp. 416-426. Oxford University Press 10.1093/ehjdh/ztae029

Preview

Text ztae029.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC). Download (53MB) | Preview

AIMS

Recently, deep learning artificial intelligence (AI) models have been trained to detect cardiovascular conditions, including hypertrophic cardiomyopathy (HCM), from the 12-lead electrocardiogram (ECG). In this external validation study, we sought to assess the performance of an AI-ECG algorithm for detecting HCM in diverse international cohorts.

METHODS AND RESULTS

A convolutional neural network-based AI-ECG algorithm was developed previously in a single-centre North American HCM cohort (Mayo Clinic). This algorithm was applied to the raw 12-lead ECG data of patients with HCM and non-HCM controls from three external cohorts (Bern, Switzerland; Oxford, UK; and Seoul, South Korea). The algorithm's ability to distinguish HCM vs. non-HCM status from the ECG alone was examined. A total of 773 patients with HCM and 3867 non-HCM controls were included across three sites in the merged external validation cohort. The HCM study sample comprised 54.6% East Asian, 43.2% White, and 2.2% Black patients. Median AI-ECG probabilities of HCM were 85% for patients with HCM and 0.3% for controls (P < 0.001). Overall, the AI-ECG algorithm had an area under the receiver operating characteristic curve (AUC) of 0.922 [95% confidence interval (CI) 0.910-0.934], with diagnostic accuracy 86.9%, sensitivity 82.8%, and specificity 87.7% for HCM detection. In age- and sex-matched analysis (case-control ratio 1:2), the AUC was 0.921 (95% CI 0.909-0.934) with accuracy 88.5%, sensitivity 82.8%, and specificity 90.4%.

CONCLUSION

The AI-ECG algorithm determined HCM status from the 12-lead ECG with high accuracy in diverse international cohorts, providing evidence for external validity. The value of this algorithm in improving HCM detection in clinical practice and screening settings requires prospective evaluation.

Interest & Impact

Downloads

2 since deposited on 31 Jul 2024
2 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item